PubRank

A Kallioniemi

Author PubWeight™ 94.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998 25.41
2 Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994 5.52
3 Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998 4.22
4 Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997 4.02
5 Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000 3.83
6 ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci U S A 1992 3.25
7 New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 2001 2.69
8 Genome screening by comparative genomic hybridization. Trends Genet 1997 2.23
9 Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci U S A 2001 2.16
10 Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol 1993 2.09
11 Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer 1999 2.05
12 Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 1994 1.93
13 Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res 2000 1.92
14 Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 1996 1.89
15 Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 2000 1.86
16 Computer image analysis of comparative genomic hybridization. Cytometry 1995 1.80
17 Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry 1994 1.39
18 Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res 1995 1.38
19 Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 1995 1.34
20 Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997 1.34
21 Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer. Endocr Relat Cancer 2006 1.27
22 A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis. Genomics 1995 1.24
23 CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors. Anal Cell Pathol 2001 1.22
24 Comparative genomic hybridization in clinical cytogenetics. Am J Hum Genet 1995 1.15
25 Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res 1992 1.11
26 Improved procedure for fluorescence in situ hybridization on tissue microarrays. Cytometry 2001 1.08
27 Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann Oncol 2007 1.06
28 Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer 1997 1.03
29 Molecular cytogenetics of human breast cancer. Cold Spring Harb Symp Quant Biol 1994 1.02
30 Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. Cancer Genet Cytogenet 2000 0.98
31 c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol 1995 0.97
32 Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 1994 0.93
33 Extrachromosomal gene amplification in acute myeloid leukemia; characterization by metaphase analysis, comparative genomic hybridization, and semi-quantitative PCR. Genes Chromosomes Cancer 1993 0.91
34 The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients. Breast 2013 0.90
35 Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies. J Med Genet 2006 0.89
36 Applications of fluorescence in situ hybridization in biological dosimetry and detection of disease-specific chromosome aberrations. Prog Clin Biol Res 1991 0.88
37 High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer. Br J Cancer 2007 0.87
38 Physical mapping of chromosome 17 cosmids by fluorescence in situ hybridization and digital image analysis. Genomics 1994 0.86
39 High-resolution physical and genetic mapping of the critical region for Meckel syndrome and Mulibrey Nanism on chromosome 17q22-q23. Genome Res 1999 0.84
40 Molecular cytogenetic mapping of 24 CEPH YACs and 24 gene-specific large insert probes to chromosome 17. Cytogenet Cell Genet 1998 0.83
41 Acoustic properties of trabecular bone--relationships to tissue composition. Ultrasound Med Biol 2007 0.83
42 From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome. Semin Cancer Biol 2001 0.81
43 Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer. Genes Chromosomes Cancer 1999 0.79
44 Molecular cytogenetics: diagnosis and prognostic assessment. Curr Opin Biotechnol 1992 0.78
45 Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction. Breast Cancer Res Treat 1996 0.77
46 Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer. Acta Oncol 1990 0.75